Gerald Parker
Impact in
Papers in
-
- Botulinum Toxin and Related Neurological Disorders 3
- Neurological disorders and treatments 1
-
- Chronic Kidney Disease and Diabetes 1
- Co-authors
- Michael T. Osterholm (7 shared papers)Donald A. Henderson (7 shared papers)JEROME M. HAUER (7 shared papers)Tom Inglesby, Jr. (7 shared papers)Kevin Tonat (7 shared papers)Trish M. Perl (7 shared papers)Michael S. Ascher (7 shared papers)Edward M. Eitzen (7 shared papers)
- Journals
- JAMA (7 papers)Toxicon (1 paper)The American Journal of the Medical Sciences (1 paper)Journal of Surgical Research (1 paper)Clinical Gastroenterology and Hepatology (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Gerald Parker
12 papers receiving 5.9k citations
Gerald Parker's Hit Papers
Peers
Comparison fields: 5 of 140
- Virology 970
- Genetics 2.4k
- Emergency Medical Services 480
- Neurology 1.1k
- Infectious Diseases 1.2k
Countries citing papers authored by Gerald Parker
This map shows the geographic impact of Gerald Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Parker more than expected).
Fields of papers citing papers by Gerald Parker
This network shows the impact of papers produced by Gerald Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Parker. The network helps show where Gerald Parker may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerald Parker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Botulinum Toxin as a Biological Weapon Hit paper breakdown → | 2001 | 1482 |
| 2 | Smallpox as a Biological Weapon Hit paper breakdown → | 1999 | 1290 |
| 3 | Tularemia as a Biological Weapon Hit paper breakdown → | 2001 | 1133 |
| 4 | Anthrax as a Biological Weapon, 2002 Hit paper breakdown → | 2002 | 841 |
| 5 | Plague as a Biological Weapon Hit paper breakdown → | 2000 | 781 |
| 6 | 1999 | 696 | |
| 7 | Botulinum toxin as a biological weapon | 2001 | 112 |
| 8 | 2013 | 112 | |
| 9 | 2011 | 66 | |
| 10 | 1995 | 37 | |
| 11 | 1982 | 3 | |
| 12 | 2010 | 3 |
About Gerald Parker
Gerald Parker is a scholar working on Neurology, Nephrology, Molecular Biology, Endocrinology and Emergency Medical Services, having authored 12 papers that have together received 6.6k indexed citations. Recurring topics across this work include Bacillus and Francisella bacterial research (4 papers), Botulinum Toxin and Related Neurological Disorders (3 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Diphtheria, Corynebacterium, and Tetanus (1 paper), Zoonotic diseases and public health (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Neurological disorders and treatments (1 paper) and Disaster Response and Management (1 paper). The work is most often cited by research in Virology (970 citations), Genetics (2.4k citations), Emergency Medical Services (480 citations), Neurology (1.1k citations) and Infectious Diseases (1.2k citations). Gerald Parker has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Michael T. Osterholm, Donald A. Henderson, JEROME M. HAUER, Tom Inglesby, Jr., Kevin Tonat, Trish M. Perl, Michael S. Ascher, Edward M. Eitzen, John Gilles Bartlett and Philip K. Russell. Their work appears in journals such as JAMA, Toxicon, The American Journal of the Medical Sciences, Journal of Surgical Research and Clinical Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.